• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 09, 2023 at 10:42: PM
via Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and DivcoWest, a DivCore Capital Company, announced today plans for Astellas to open a new state-of-the-art life sciences facility at 441 Morgan Avenue, in the Cambridge Crossing (CX) neighborhood in Cambridge, Mass. This investment establishes a significant presence for Astellas in one of the world's premier life science innovation hubs, showcasing the company's commitment to expanding its R&D footprint in order to accelerate innovation and deliver VALUE to patients.

article source
 

<



Similar threads

cafead
Astellas Pharma Plans to Open New Biotech Facility in California
Replies
0
Views
122
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Astellas to Open New Biotech Campus in South San Francisco
Replies
0
Views
169
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Astellas brings its first digital health product to US
Replies
0
Views
2
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Astellas unveils Massachusetts lab that will be shared with biotechs, academia researchers
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Japan&#039;s Astellas says employee indicted by China&#039;s prosecutors
Replies
0
Views
25
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote